Preventing Prostate Cancer - Cholesterol + Statins
Tuesday, October 28 2008 00:00
New effort to find out if anti-cholesterol drugs can help reduce men's risk of prostate cancer
Popular cholesterol-busting drugs called statins appear to lower men's PSA values along with their cholesterol levels according to researchers in the Duke Prostate Center and the Durham Veterans Affairs Medical Center. But whether the drugs prevent prostate cancer growth or just mask it is not known yet.
Read more: Statins May Lower PSA, But Do They Cut Cancer Risk?
Bone Pain Control Using MRI and Ultrasound
Saturday, November 15 2008 13:49
Magnetic resonance-guided focused ultrasound surgery (MRgFUS), a noninvasive thermal ablation technique that has been shown to be clinically effective in the treatment of uterine fibroids, is now being evaluated as a method for treating painful bone metastases.
Now physicians in North America are running a full scale clinical trial to see if the method really does work as well or better than traditional pain management methods.
Treatments - Active Surveillance
Sunday, June 15 2008 00:00
Active Surveillance for Low-Risk Prostate Cancer Demands Careful Selection, Study Says
Active surveillance followed by selective treatment for men who have evidence of disease progression may be an option for some patients with early-stage prostate cancer.
Read more: UCSF Active Surveillance for low-risk prostate cancer
The Case for PSA Screening Starting at Age 40
Diagnosis + Stage - Screening for prostate cancer
Friday, October 31 2008 00:00
When men should take their first PSA test to screen for prostate cancer is an issue that comes up constantly in discussions of mens' health.
The National Comprehensive Cancer Care Network (NCCN) recommends men to take their first PSA test at age 40. How soon and how often to take a follow-up PSA tests would then depend on this initial level.
Page 8 of 8
